263 related articles for article (PubMed ID: 18056166)
1. Interleukin-21 signaling: functions in cancer and autoimmunity.
Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV
Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166
[TBL] [Abstract][Full Text] [Related]
2. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses.
Habib T; Nelson A; Kaushansky K
J Allergy Clin Immunol; 2003 Dec; 112(6):1033-45. PubMed ID: 14657853
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-21: a new modulator of immunity, infection, and cancer.
Brandt K; Singh PB; Bulfone-Paus S; Rückert R
Cytokine Growth Factor Rev; 2007; 18(3-4):223-32. PubMed ID: 17509926
[TBL] [Abstract][Full Text] [Related]
4. IL-21: roles in immunopathology and cancer therapy.
Søndergaard H; Skak K
Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
[TBL] [Abstract][Full Text] [Related]
5. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
6. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
[TBL] [Abstract][Full Text] [Related]
7. Biology of IL-21 and the IL-21 receptor.
Mehta DS; Wurster AL; Grusby MJ
Immunol Rev; 2004 Dec; 202():84-95. PubMed ID: 15546387
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-21 in immune-regulation and tumor immunotherapy.
di Carlo E; de Totero D; Piazza T; Fabbi M; Ferrini S
Cancer Immunol Immunother; 2007 Sep; 56(9):1323-34. PubMed ID: 17447063
[TBL] [Abstract][Full Text] [Related]
9. Immune modulation with interleukin-21.
Bhave NS; Carson WE
Ann N Y Acad Sci; 2009 Dec; 1182():39-46. PubMed ID: 20074273
[TBL] [Abstract][Full Text] [Related]
10. Immune enhancement and anti-tumour activity of IL-23.
Hao JS; Shan BE
Cancer Immunol Immunother; 2006 Nov; 55(11):1426-31. PubMed ID: 16676182
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21: an interleukin-2 dependent player in rejection processes.
Baan CC; Balk AH; Dijke IE; Korevaar SS; Peeters AM; de Kuiper RP; Klepper M; Zondervan PE; Maat LA; Weimar W
Transplantation; 2007 Jun; 83(11):1485-92. PubMed ID: 17565322
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.
Parrish-Novak J; Foster DC; Holly RD; Clegg CH
J Leukoc Biol; 2002 Nov; 72(5):856-63. PubMed ID: 12429707
[TBL] [Abstract][Full Text] [Related]
13. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory and antitumor effects of interleukin-21 in patients with renal cell carcinoma.
Curti BD
Expert Rev Anticancer Ther; 2006 Jun; 6(6):905-9. PubMed ID: 16761934
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 21 enhances antibody-mediated tumor rejection.
Smyth MJ; Teng MW; Sharkey J; Westwood JA; Haynes NM; Yagita H; Takeda K; Sivakumar PV; Kershaw MH
Cancer Res; 2008 Apr; 68(8):3019-25. PubMed ID: 18413772
[TBL] [Abstract][Full Text] [Related]
16. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.
Liu R; Bai Y; Vollmer TL; Bai XF; Jee Y; Tang YY; Campagnolo DI; Collins M; Young DA; La Cava A; Shi FD
Exp Neurol; 2008 May; 211(1):14-24. PubMed ID: 18353312
[TBL] [Abstract][Full Text] [Related]
17. IL-9 and its receptor: from signal transduction to tumorigenesis.
Knoops L; Renauld JC
Growth Factors; 2004 Dec; 22(4):207-15. PubMed ID: 15621723
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-13 in regulation of anti-tumor immunity and tumor growth.
Terabe M; Park JM; Berzofsky JA
Cancer Immunol Immunother; 2004 Feb; 53(2):79-85. PubMed ID: 14610620
[TBL] [Abstract][Full Text] [Related]
19. The role of IL-21 in hematological malignancies.
Ma J; Ma D; Ji C
Cytokine; 2011 Nov; 56(2):133-9. PubMed ID: 21824785
[TBL] [Abstract][Full Text] [Related]
20. The IL-17 cytokine family.
Gaffen SL; Kramer JM; Yu JJ; Shen F
Vitam Horm; 2006; 74():255-82. PubMed ID: 17027518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
